Holen Sie sich die Stockscreener-App
24.86
0.10%
0.0026
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BAX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$24.86
Offen:
$24.71
24-Stunden-Volumen:
1.39M
Relative Volume:
0.22
Marktkapitalisierung:
$12.86B
Einnahmen:
$11.32B
Nettoeinkommen (Verlust:
$-981.00M
KGV:
-12.73
EPS:
-1.9532
Netto-Cashflow:
$714.00M
1W Leistung:
-3.17%
1M Leistung:
-9.67%
6M Leistung:
+38.94%
1J Leistung:
+1.78%
1-Tages-Spanne:
$24.47
$25.20
1-Wochen-Bereich:
$24.47
$26.11
52-Wochen-Spanne:
$15.73
$30.00
Baxter International Inc Stock (BAX) Company Profile
Firmenname
Baxter International Inc
Sektor
Telefon
(224) 948-2000
Adresse
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
24.88 | 12.85B | 11.32B | -981.00M | 714.00M | -1.9532 |
ISRG
Intuitive Surgical Inc
|
351.58 | 123.70B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
180.32 | 48.78B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
69.05 | 33.41B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
219.75 | 31.89B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
34.38 | 30.44B | 29.14B | 1.07B | 1.05B | 1.1956 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-31 | Herabstufung | Argus | Buy → Hold |
| 2025-08-04 | Herabstufung | Stifel | Buy → Hold |
| 2025-08-01 | Herabstufung | Goldman | Buy → Neutral |
| 2025-02-26 | Fortgesetzt | Goldman | Buy |
| 2025-02-24 | Hochstufung | Argus | Hold → Buy |
| 2025-02-20 | Fortgesetzt | Barclays | Overweight |
| 2024-07-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-12-19 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-12-15 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-12-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-06-24 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Herabstufung | Goldman | Neutral → Sell |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-18 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | Bestätigt | Morgan Stanley | Overweight |
| 2022-02-18 | Bestätigt | Raymond James | Outperform |
| 2022-02-18 | Bestätigt | Stifel | Buy |
| 2022-02-18 | Bestätigt | UBS | Neutral |
| 2022-02-18 | Bestätigt | Wells Fargo | Overweight |
| 2022-02-11 | Eingeleitet | Goldman | Neutral |
| 2022-01-07 | Fortgesetzt | Citigroup | Buy |
| 2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | Hochstufung | Cowen | Market Perform → Outperform |
| 2021-09-03 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-05-25 | Eingeleitet | Barclays | Equal Weight |
| 2021-01-29 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | Herabstufung | UBS | Buy → Neutral |
| 2020-12-15 | Herabstufung | Goldman | Buy → Neutral |
| 2020-10-01 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-09-04 | Herabstufung | Argus | Buy → Hold |
| 2020-06-24 | Eingeleitet | Oppenheimer | Outperform |
| 2020-03-19 | Hochstufung | Stifel | Hold → Buy |
| 2020-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-02 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-17 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-01-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-01-02 | Hochstufung | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | Hochstufung | Argus | Hold → Buy |
| 2018-10-16 | Eingeleitet | Barclays | Underweight |
| 2018-05-17 | Fortgesetzt | Piper Jaffray | Overweight |
| 2018-02-06 | Bestätigt | Citigroup | Neutral |
| 2018-01-03 | Eingeleitet | Evercore ISI | Outperform |
| 2018-01-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
Alle ansehen
Baxter International Inc Aktie (BAX) Neueste Nachrichten
A Look at Baxter International Inc (BAX) After 3.8% Decline -- G - GuruFocus
Baxter International stock trades sideways as technical signals flag limited near-term upside - AD HOC NEWS
Baxter International Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Baxter International stock holds steady as investors await next earnings signal - AD HOC NEWS
BAX Raises 2026 Outlook as Strong Q2 Growth Offsets Margin Pressure - Yahoo Finance
Human Albumin Market Report Analyzes Growth Factors, Challenges, and Market Dynamics - openPR.com
Drug Reconstitution Systems Market Trends, Shares and Growth Opportunities Worldwide 2026-2035 Featuring Profiles of Baxter, ICU Medical, B. Braun, Vetter Pharma, Nipro, SCHOTT-KAISHA - GlobeNewswire Inc.
Don't Ignore The Insider Selling In Abeona Therapeutics - simplywall.st
Baxter International Inc. (BAX) Stock Analysis: Exploring Potential Upside and Analyst Ratings - DirectorsTalk Interviews
Nagaraj Bhat Appointed Vice President/GM, Global Capability Center (GCC) Site Leader at DePuy Synthes - hrtoday.in
Baxter International stock holds steady as investors focus on recent restructuring and earnings prof - AD HOC NEWS
ETFs Investing in Baxter International Inc. Stocks - TradingView
Before Mark Walter’s companies faced inquiries, he kept a low profile and built loyalty - Los Angeles Times
Two IV Saline Recalls Within Days Cite Iron Oxide and Fiberglass Particles Found Inside Sealed Hospital Bags - Medical Daily
IV bags recalled in MD over potential fiberglass contamination - Maryland Daily Record
Baxter International Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Baxter International stock holds steady as investors digest latest quarterly figures - AD HOC NEWS
Jerry Flansburg Obituary (2026)International Falls, MNRainy Lake Gazette - Legacy obituary
Baxter International's Julie Foster Reports RSU-Related Share Forfeiture - Kalkine Media
Recalls issued for possible fiberglass particles in IV solutions made at WNC facility: FDA - WLOS
Baxter International stock gains after strong Q2 figures - AD HOC NEWS
Taiwan's Best Companies to Work for in Asia Transformed a Talent Crisis into a Strategic Advantage - PR Newswire
Baxter International stock holds gains as recalls and earnings shape sentiment - AD HOC NEWS
Baxter International stock could double, Tom Hayes says - Yahoo Finance
FDA recalls saline bags in 14 states over possible fiberglass contamination - thecooldown.com
Baxter International stock steadies as recall news meets mixed analyst view - AD HOC NEWS
Baxter International Inc. (BAX) Stock Analysis: Exploring a 9.94% Potential Upside Amidst Healthcare Sector Dynamics - DirectorsTalk Interviews
2 drugs recalled over potential fiberglass, steel presence - WGN-TV
Saline bags recalled in 14 states due to potential fiberglass contamination - kare11.com
Fiberglass in IV saline? Texas among states included in recall - MySA
Baxter International Inc. (BAX) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Saline used in IV injections recalled nationwide due to fiberglass - FOX 8 News
Baxter International Inc. stock outperforms competitors despite losses on the day - MarketWatch
Several Baxter vaccine, solution lots recalled due to potential ‘particulate matter’ - WFMJ
Licensable picture: Baxter International CEO and President Robert Parkinson Jr. looks over at the families of the victims of Heparin reactions testifying during a House Energy and Commerce subcommittee hearing on Heparin imports from China on Capitol Hill - reutersconnect.com
Baxter Recalls an IV Nutrition Solution After Stainless Steel Particles Turned Up Inside the Sterile Bag - medicaldaily.com
Baxter Issues Voluntary Nationwide Recall for One Lot of 70% Dextrose Injection Due to Potential Presence of Particulate Matter - EIN News
Baxter International Inc. (BAX) Stock Analysis: Navigating Challenges with Potential 9.06% Upside - DirectorsTalk Interviews
Baxter International stock holds steady as new CFO joins and analyst estimates shift - Ad-hoc-news.de
Zacks Research Issues Negative Estimate for BAX Earnings - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Takes Position in Baxter International Inc. $BAX - MarketBeat
Baxter International (BAX) Taps John Rogers As Chief Financial Officer - Sahm
Baxter hires new CFO with visa contingency - CFO Dive
Baxter hires CFO from Smith & Nephew - MedTech Dive
1,435,460 Shares in Baxter International Inc. $BAX Acquired by Tocqueville Asset Management L.P. - MarketBeat
Edmond DE Rothschild Holding S.A. Acquires New Shares in Baxter International Inc. $BAX - MarketBeat
Great Lakes Advisors LLC Purchases New Holdings in Baxter International Inc. $BAX - MarketBeat
BlackRock Inc. Makes New $1.74 Billion Investment in Baxter International Inc. $BAX - MarketBeat
Smith+Nephew CFO joins Baxter - MassDevice
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Baxter finds its replacement finance chief, reaffirms outlook - Crain's Chicago Business
Finanzdaten der Baxter International Inc-Aktie (BAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
0.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):